V
IMGN

Veritable’s Immunogen Inc IMGN Stock Holding History

Veritable’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-44,750
Closed -$607K – 758
2015
Q4 		$607K Sell
44,750
-414
-0.9% -$5.1K 0.02% 418
2015
Q3 		$434K Buy
45,164
+110
+0.2% +$1.61K 0.01% 489
2015
Q2 		$648K Sell
45,054
-4,928
-10% -$54.1K 0.02% 401
2015
Q1 		$447K Buy
+49,982
New +$362K 0.01% 633
2014
Q4 		– Sell
-14,068
Closed -$149K – 990
2014
Q3 		$149K Buy
14,068
+719
+5% +$8.13K ﹤0.01% 926
2014
Q2 		$158K Hold
13,349
– – ﹤0.01% 914
2014
Q1 		$199K Sell
13,349
-405
-3% -$6.38K ﹤0.01% 862
2013
Q4 		$202K Buy
13,754
+1,153
+9% +$17.7K ﹤0.01% 835
2013
Q3 		$214K Buy
12,601
+410
+3% +$7.21K 0.01% 849
2013
Q2 		$202K Buy
+12,191
New +$198K ﹤0.01% 863

Other funds holding IMGN

ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Veritable's IMGN Position: Q1 2016 in Review

Veritable sold out of Immunogen Inc (IMGN) in Q1 2016, closing a stake of 44,750 shares — an estimated $607K sold.

Veritable first reported a position in IMGN in Q2 2013 and held it in 10 quarters. The position peaked at $648K in Q2 2015. 143 funds tracked by Wall St. Rank hold IMGN as of Q1 2016.

  • Veritable reported no remaining Immunogen Inc position as of Q1 2016 after selling out during the quarter.
  • Veritable sold 44,750 Immunogen Inc shares in Q1 2016, an estimated $607K.
  • Veritable first reported a position in Immunogen Inc in Q2 2013 and held it in 10 quarters.
  • Veritable's Immunogen Inc position peaked at $648K in Q2 2015.
  • 143 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2016.

Based on Veritable's 13F filing for Q1 2016, filed 16 May 2016.